Iovance Biotherapeutics股票讨论区

$Iovance Biotherapeutics(IOVA.US)$ Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer
4 MINUTES AGO, 6:30 AM EST
VIA GLOBENEWSWIRE

hhh, reenter.. I should have stopped daytrade better swing for biotech, easier to get gain if got FDA approval...
$生物技术(BK2069.US)$
$Iovance Biotherapeutics(IOVA.US)$

$Iovance Biotherapeutics(IOVA.US)$
Shorties gonna b the Johnny come lately?
$AMC院线(AMC.US)$ $游戏驿站(GME.US)$ $优步(UBER.US)$ $DraftKings(DKNG.US)$ $ARK Innovation ETF(ARKK.US)$ $特斯拉(TSLA.US)$ $Affirm Holdings(AFRM.US)$ $拼多多(PDD.US)$

4 FDA approvals last week
1 PDUFA event left in Feb 2024
Last week’s PDUFAs:
$阿斯利康(AZN.US)$ : Approved 2/16
⇒ Tagrisso (osimertinib) + chemotherapy
⇒ NSCLC
⇒ sNDA
⇒ PDUFA: Q1 2024
$Iovance Biotherapeutics(IOVA.US)$ : Approved 2/16
⇒  AMTAGVI™ (lifileucel)
⇒ Melanoma
⇒ BLA
⇒ PDUFA: 02/24/24
$罗氏(ADR)(RHHBY.US)$ : Approved 2/16
⇒ Xolair® (omalizumab)
⇒ IgE-mediated food allergy
⇒ sBLA
⇒ PDUFA: Q1 2024
$IPSEY & $Merrimack Pharmaceuticals(MACK.US)$ : Approved 2/13
⇒ ...

$Iovance Biotherapeutics(IOVA.US)$
02/20/2024 - 06:30 AM
SAN CARLOS, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (Nasdaq: IOVA) (“Iovance” or “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced the pricing of an underwritten offering of 23,014,000 shares of its common stock at an offering price of $9.15 per sh...

$Iovance Biotherapeutics(IOVA.US)$ Iovance Biotherapeutics, Inc. Announces Pricing of $211 Million Underwritten Offering of Common Stock
2 MINUTES AGO, 6:30 AM EST
VIA GLOBENEWSWIRE